结核性脑膜炎实验室诊断方法及其改进策略

王义义综述,张伟审校

武警医学 ›› 2018, Vol. 29 ›› Issue (7) : 735-737.

PDF(588 KB)
PDF(588 KB)
武警医学 ›› 2018, Vol. 29 ›› Issue (7) : 735-737.
综述

结核性脑膜炎实验室诊断方法及其改进策略

  • 王义义1综述,张伟2审校
作者信息 +
文章历史 +

引用本文

导出引用
王义义综述,张伟审校. 结核性脑膜炎实验室诊断方法及其改进策略[J]. 武警医学. 2018, 29(7): 735-737
中图分类号: R446   

参考文献

[1] Bidstrup C, Andersen P H,Skinhoj P, et al. Tuberculous meningitis in a country with a low incidence of tuberculosis: still a serious disease and a diagnostic challenge[J]. Scand J Infect Dis, 2002,34(11): 811-814.
[2] Ruslami R, Ganiem A R,Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial[J]. Lancet Infect Dis, 2013, 13(1): 27-35.
[3] McNerney R, Maeurer M, Abubakar I, et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities[J]. J Infect Dis, 2012,205 Suppl 2: S147-5158.
[4] Thwaites G E.Tuberculous meningitis: many questions, too few answers[J]. Lancet Neurol, 2005, 4(3): 160-170.
[5] Garcia-Monco J C.Central nervous system tuberculosis[J]. Neurol Clin, 1999. 17(4): 737-759.
[6] Thwaites G E. Improving the bacteriological diagnosis of tuberculous meningitis[J]. J Clin Microbiol, 2004, 42(1): 378-379.
[7] Steingart K R, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review[J]. Lancet Infect Dis, 2006, 6(9): 570-581.
[8] Erdem H, Ozturk-Engin D, Elaldi N, et al. The microbiological diagnosis of tuberculous meningitis: results of Haydarpasa-1 study[J]. Clin Microbiol Infect, 2014, 20(10): 600-608.
[9] Tortoli E, Cichero P, Piersimoni C, et al. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study[J]. J Clin Microbiol, 1999, 37(11): 3578-3582.
[10] Venkataswamy M M. Comparative evaluation of BACTEC 460TB system and Lowenstein-Jensen medium for the isolation of M. tuberculosis from cerebrospinal fluid samples of tuberculous meningitis patients[J]. Indian J Med Microbiol, 2007, 25(3): 236-240.
[11] Pfyffer G E.Incubation time of mycobacterial cultures: how long is long enough to issue a final negative report to the clinician? [J]. J Clin Microbiol, 2012, 50(12): 4188-4189.
[12] Caviedes L, Lee T S, Gilman R H, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru[J]. J Clin Microbiol, 2000, 38(3): 1203-1208.
[13] Caws M, Dang T M, Torok E, et al. Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis[J]. PLoS One, 2007, 2(11): e1173.
[14] Coronel J, Roper M, Mitchell S, et al. MODS accreditation process for regional reference laboratories in Peru: validation by GenoType(R) MTBDRplus[J]. Int J Tuberc Lung Dis, 2010, 14(11): 1475-1480.
[15] Kaneko K, Onodera O, Miyatake T,et al. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR) [J]. Neurology, 1990, 40(10): 1617-1618.
[16] Torok M E. Tuberculous meningitis: advances in diagnosis and treatment[J]. Br Med Bull, 2015, 113(1): 117-131.
[17] Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection[J]. Health Technol Assess, 2007, 11(3): 1-196.
[18] Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology[J]. J Clin Microbiol, 2010,48(1): 229-237.
[19] Patel V B, Theron G, Lenders L, et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study[J]. PLoS Med, 2013, 10(10): e1001536.
[20] Nhu N T, Heemskerk D, Thu do D A, et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis[J]. J Clin Microbiol, 2014, 52(1): 226-233.
[21] Moore D A. Alternative methods of diagnosing drug resistance--what can they do for me? [J]. J Infect Dis, 2011, 204 Suppl 4: S1110-1119.
[22] Khan T A, Mazhar H, Saleha S, et al. Interferon-Gamma Improves Macrophages Function against M. tuberculosis in Multidrug-Resistant Tuberculosis Patients[J]. Chemother Res Pract, 2016: 7295390.
[23] Metcalfe J Z, Everett C K, Steingart K R, et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis[J]. J Infect Dis, 2011, 204 Suppl 4: S1120-1129.
[24] Kim S H, Cho O H, Park S J, et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells[J]. Clin Infect Dis, 2010, 50(10): 1349-1358.
[25] Patel V B, Cho O H,Park S J, et al. Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population[J]. Am J Respir Crit Care Med, 2010, 182(4): 569-577.
[26] Vidhate M R, Singh M K, Garg R K, et al. Diagnostic and prognostic value of Mycobacterium tuberculosis complex specific interferon gamma release assay in patients with tuberculous meningitis[J]. J Infect, 2011, 62(5): 400-403.
[27] Morris K. WHO recommends against inaccurate tuberculosis tests[J]. Lancet, 2011, 377(9760): 113-114.
[28] Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians[J]. J Infect Dis, 2001, 183(3): 469-477.
[29] Kashyap R S, Ramteke S S, Morey S H, et al. Diagnostic value of early secreted antigenic target-6 for the diagnosis of tuberculous meningitis patients[J]. Infection, 2009,37(6): 508-513.
[30] Lawn S D.Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications[J]. Trans R Soc Trop Med Hyg, 2016, 110(3): 180-185.
[31] Gupta-Wright A, Peters J A, Flach C, et al. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis[J]. BMC Med, 2016,14: 53.
[32] Rock R B, Olin M, Baker CA, et al. Central nervous system tuberculosis: pathogenesis and clinical aspects[J]. Clin Microbiol Rev, 2008, 21(2): 243-261.
[33] Tuon F F. Adenosine deaminase and tuberculous meningitis--a systematic review with meta-analysis[J]. Scand J Infect Dis, 2010, 42(3): 198-207.
     

PDF(588 KB)

Accesses

Citation

Detail

段落导航
相关文章

/